Getting Ozempic comes down to two steps: a prescriber who agrees it's right for you, and a way to pay. The prescription is the harder part if you don't have diabetes, because that's the only condition Ozempic is approved to treat [1]. The payment part has three routes, and the price gap between them runs from $25 to $499 a month.
| Route | Who it's for | What you pay | Conditions |
|---|---|---|---|
| Commercial insurance + savings card | People whose employer or marketplace plan covers Ozempic | As little as $25 a month | Savings capped at $100 a month; government insurance excluded [3] |
| NovoCare self-pay, new patients | Anyone with a prescription, paying cash | $199 a month for 2 fills of 0.25 or 0.5 mg | Through December 31, 2026 [3] |
| NovoCare self-pay, after that | Anyone with a prescription, paying cash | $349 a month (0.25, 0.5 or 1 mg); $499 a month (2 mg) | One month = one box with one pen [3] |
| Medicare Part D | Medicare enrollees with type 2 diabetes | Your plan's cost share | Plan drug list and any prior authorization apply |
| Over the counter | No one | Not available | Prescription required |
Maker and Medicare figures as currently published. Medicare details are in our guide to whether Medicare covers Ozempic.
Ozempic is approved for type 2 diabetes, and only that
Every use on Ozempic's label is in adults with type 2 diabetes. The weekly injection is approved to improve blood sugar alongside diet and exercise, to lower the risk of heart attack, stroke and cardiovascular death in people who already have heart disease, and to slow kidney decline in people who also have chronic kidney disease [1].
There's also an Ozempic tablet now, taken once a day. It shares a label with Rybelsus and carries two uses: blood sugar control, and lowering heart-event risk in adults with type 2 diabetes who are at high risk [2]. Doses for both forms are covered in how Ozempic is taken.
Weight loss isn't on either label. FDA says prescribers may generally use an approved drug for an unapproved use “when they judge that it is medically appropriate for their patient” [5]. Whether your insurance pays for an off-label use is a separate question, decided by your plan's own drug list and rules.
Step 1: get a prescription, in person or by telehealth
A licensed prescriber has to decide Ozempic fits you. That can be your primary care doctor, an endocrinologist, or a clinician at a telehealth program licensed in your state. Expect questions about your health history, your other medicines and your diabetes care. Which lab tests they want, and when, is up to them.
Telehealth is a common route now, and quality varies. What to check before you book is laid out in GLP-1 telehealth, explained. Programs that prescribe brand Ozempic include Ro, Fridays and Maximus. Their visit and membership fees come on top of what the pharmacy charges for the drug, so add both before you compare.
Step 2: with insurance, the savings card can bring it to $25
If your plan covers Ozempic, Novo Nordisk's savings offer can cut your copay to as little as $25, with savings capped at $100 a month [3]. The offer is for commercial insurance only. Its terms exclude government beneficiaries, so people on government-funded coverage such as Medicare or Medicaid can't use it.
Many plans ask for prior authorization first. That's a form your prescriber sends to show the drug is being used for a covered reason, usually type 2 diabetes. If your plan turns it down, ask your prescriber about an appeal or the plan's exception process before you switch to cash.
Step 3: without insurance, NovoCare sells it at a flat price
Novo Nordisk sells Ozempic directly through NovoCare Pharmacy. New patients pay $199 a month for two monthly fills of 0.25 mg or 0.5 mg, through December 31, 2026. After that it's $349 a month for the 0.25, 0.5 or 1 mg pen and $499 a month for the 2 mg pen [3]. A month here means one box with one pen.
Count boxes, not calendar months. Each pen holds four weekly doses, so a year takes 13 boxes: about $4,537 at $349, or $6,487 for the 2 mg pen, by our arithmetic. The tablet starts at $149 a month for the 1.5 mg starting dose [3]. Every cash price, including pharmacy and discount routes, is in Ozempic cost without insurance, and brand self-pay programs are compared in brand GLP-1 self-pay programs, scored.
Medicare covers Ozempic for diabetes, not through the $50 Bridge
Medicare drug plans can cover Ozempic when it's prescribed for its labeled diabetes uses, subject to each plan's drug list. Medicare's temporary GLP-1 Bridge, which charges $50 a month, covers Foundayo, Wegovy and the Zepbound KwikPen for weight management. Ozempic isn't on that list, and people with type 2 diabetes don't qualify for the Bridge [4].
The Part D cost stages, the yearly out-of-pocket cap and the negotiated price coming in 2027 are covered in does Medicare cover Ozempic.
You can't buy Ozempic over the counter, and FDA warns about fakes
Ozempic is prescription-only, so any seller offering it without a prescription isn't a legitimate pharmacy. FDA puts it plainly: “FDA is aware of counterfeit Ozempic marketed in the U.S.” [6] Counterfeits can contain the wrong ingredient, too much or too little of the right one, or none at all.
FDA has also warned companies selling semaglutide labeled “for research purposes” or “not for human consumption” and urges people not to buy those products [6]. To check an online pharmacy, FDA's BeSafeRx program explains the warning signs and links to state license lookups [8].
Supply is not the obstacle it once was. FDA declared the shortage of semaglutide injection products resolved on February 21, 2025, and says semaglutide is not on its drug shortage list [7].
Want it for weight loss? Wegovy is the semaglutide labeled for that
If your goal is weight, the same molecule is sold as Wegovy, which is approved for long-term weight reduction and comes in higher doses than Ozempic. That label matters for coverage too: Wegovy, not Ozempic, is the semaglutide in Medicare's $50 Bridge. How the two compare is in Ozempic vs Wegovy, and Wegovy's prices are in what Wegovy costs.
Compounded semaglutide is a different product, not Ozempic
Some telehealth programs sell compounded semaglutide, made by a pharmacy rather than by Novo Nordisk. It isn't Ozempic and shouldn't be sold as Ozempic. Compounded drugs aren't FDA-approved, and FDA doesn't review their safety or effectiveness, or check their quality before they ship [6]. By May 31, 2026, FDA had received 990 reports of adverse events tied to compounded semaglutide.
Compounded semaglutide injections currently run about $75–$349 a month at the telehealth programs that sell them. How that route works is in how to get compounded semaglutide, its legal status in will compounded semaglutide be banned, and the head-to-head in compounded semaglutide vs Ozempic.